Scholarlink

Background <p>Nasopharyngeal carcinoma (NPC) typically arises from the nasopharyngeal vault and most commonly presents with cervical lymphadenopathy or otologic symptoms. Presentation with a dominant anterior sinonasal mass is exceptionally uncommon and may obscure the true site of origin, leading to diagnostic misclassification as a primary sinonasal malignancy. Cross-sectional imaging, such as computed tomography (CT), may be inconclusive in such cases, necessitating a multimodal approach for accurate diagnosis.</p> Case presentation <p>A 54-year-old Indian male presented with progressive unilateral nasal obstruction, recurrent epistaxis, facial swelling, visual impairment, and bilateral hearing loss. Nasal endoscopy revealed a bulky anterior sinonasal mass obstructing visualization of the nasopharynx. CT imaging showed a destructive mass involving the nasal cavity and paranasal sinuses with posterior extension toward the nasopharynx though the primary site remained uncertain. Incisional biopsy revealed a poorly differentiated non-keratinizing carcinoma. Immunohistochemistry (IHC) for p40/p63 and Epstein–Barr virus (EBV)-encoded RNA in situ hybridization confirmed nasopharyngeal carcinoma. Whole-body <sup>18</sup>F-fluorodeoxyglucose (FDG) positron emission tomography–computed tomography (PET-CT) demonstrated a nasopharyngeal primary with extensive loco-regional invasion, bilateral cervical nodes, and skeletal metastases (cT4bN2cM1). The patient received palliative radiotherapy but deteriorated rapidly and died shortly thereafter.</p> Conclusion <p>This case highlights a diagnostic pitfall in which nasopharyngeal carcinoma presents as a predominant anterior sinonasal mass, closely mimicking a primary sinonasal malignancy. Reliance on cross-sectional imaging alone may delay diagnosis. Early biopsy, EBV testing, and multimodal evaluation including PET-CT are essential for accurate tumor localization and staging. Awareness of this atypical presentation may help clinicians avoid diagnostic delay and optimize patient care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nasopharyngeal carcinoma masquerading as a primary sinonasal mass: a case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月20日

查看全文
  • Anurag Lahiri,
  • Niladri Roy

摘要

Background

Nasopharyngeal carcinoma (NPC) typically arises from the nasopharyngeal vault and most commonly presents with cervical lymphadenopathy or otologic symptoms. Presentation with a dominant anterior sinonasal mass is exceptionally uncommon and may obscure the true site of origin, leading to diagnostic misclassification as a primary sinonasal malignancy. Cross-sectional imaging, such as computed tomography (CT), may be inconclusive in such cases, necessitating a multimodal approach for accurate diagnosis.

Case presentation

A 54-year-old Indian male presented with progressive unilateral nasal obstruction, recurrent epistaxis, facial swelling, visual impairment, and bilateral hearing loss. Nasal endoscopy revealed a bulky anterior sinonasal mass obstructing visualization of the nasopharynx. CT imaging showed a destructive mass involving the nasal cavity and paranasal sinuses with posterior extension toward the nasopharynx though the primary site remained uncertain. Incisional biopsy revealed a poorly differentiated non-keratinizing carcinoma. Immunohistochemistry (IHC) for p40/p63 and Epstein–Barr virus (EBV)-encoded RNA in situ hybridization confirmed nasopharyngeal carcinoma. Whole-body 18F-fluorodeoxyglucose (FDG) positron emission tomography–computed tomography (PET-CT) demonstrated a nasopharyngeal primary with extensive loco-regional invasion, bilateral cervical nodes, and skeletal metastases (cT4bN2cM1). The patient received palliative radiotherapy but deteriorated rapidly and died shortly thereafter.

Conclusion

This case highlights a diagnostic pitfall in which nasopharyngeal carcinoma presents as a predominant anterior sinonasal mass, closely mimicking a primary sinonasal malignancy. Reliance on cross-sectional imaging alone may delay diagnosis. Early biopsy, EBV testing, and multimodal evaluation including PET-CT are essential for accurate tumor localization and staging. Awareness of this atypical presentation may help clinicians avoid diagnostic delay and optimize patient care.